Basics ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. IPO Date: December 14, 2012 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $306.02B Activated in VL: True Average Daily Range Avg Daily Range: $0.97 | 1.02% Avg Daily Range (30 D): $3.54 | 1.85% Avg Daily Range (90 D): $2.50 | 1.31% Institutional Daily Volume Avg Daily Volume: 6.33M Avg Daily Volume (30 D): 6.73M Avg Daily Volume (90 D): 5.13M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 60,098 Avg Inst. Trade: $9.37M Avg Inst. Trade (30 D): $26.07M Avg Inst. Trade (90 D): $23.71M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 19 Market Closing Trades Avg Closing Trade: $86.42M Avg Closing Trade (30 D): $298.21M Avg Closing Trade (90 D): $245.24M Avg Closing Volume: 793.22K         News Apr 25, 2025 @ 9:17 PM Why AbbVie Stock Topped the Market Today Source: Eric Volkman Apr 22, 2025 @ 9:37 PM Why Vertex Pharmaceuticals Was Such a Healthy Stoc... Source: Eric Volkman Apr 20, 2025 @ 12:15 PM Is AbbVie Stock a Buy? Source: Justin Pope Apr 18, 2025 @ 9:12 PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel... Source: Rosen, Global Investor Counsel Apr 18, 2025 @ 8:26 AM Atopic Dermatitis Drugs Market Forecast 2025-2034 ... Source: Researchandmarkets.Com Financials   TTM Q3 2024 Q2 2024 Basic EPS $2.87 $.88 $.77 Diluted EPS $2.87 $.88 $.77 Revenue $ 55.53B $ 14.46B $ 14.46B Gross Profit $ 37.32B $ 10.25B $ 10.26B Net Income / Loss $ 5.13B $ 1.56B $ 1.37B Operating Income / Loss $ 13.82B $ 3.83B $ 4B Cost of Revenue $ 18.21B $ 4.21B $ 4.2B Net Cash Flow $ -6030M $ -5873M $ -4937M PE Ratio 64.79